Member Info for Latino

Market

Won’t be here long... makes waking up!

Yep new management but extra special is CEO who has proven credentials...that’s steels it for me.

Also change of BOD with new CEO coming with a hugh reputation...

Not necessarily, it’s who the investors are and whether they will hold..

MMs desperately holding back..but how long for.

Paid

How many times, proof is in the pudding. CEO and new director talk a great game...but none are investing a shilling here! If this was cheap and great potential then ask yourself why they’re not buying. Keep buying and support EGHOS shift their shares lol

An update overdue...CEO?

Now dropped below open price...unbelievable!

No live quotes available!

11.97p paid on NEX

Leak?

Buys also going through on NEX, not showing I’m on LSE

Yep...market wakey wakey!

Distribution Agreement + 1st Order in the bag..excellent news.

Tissue Regenix Group PLC (LON:TRX), the regenerative medical devices company, has entered into a UK distribution agreement for its OrthoPure XT knee ligament product.

The distribution agreement, which comes with its first UK order for OrthoPure XT, is with a speciality supplier of orthopaedic and biologic products.

The distributor was not identified but Tissue Regenix’s interim chief executive officer (CEO), Gareth Jones described the party as “an ideal partner to support the commercialisation of OrthoPure XT in the UK”.

READ Tissue Regenix receives CE mark for OrthoPure XT
Under the terms of this UK distribution agreement, the NHS and private healthcare sectors will have access to OrthoPure XT. The group will initially focus on commercialisation of OrthoPure XT in the UK before commencing a gradual roll-out into certain other European countries over time.

The group said the first order, expected to be executed in the final quarter of this year, is of modest size but it is expected that demand for this product line will increase in 2021 as additional distribution opportunities are identified.

"We believe OrthoPure XT has the potential to be a disruptive product in the market for reconstruction of knee ligaments and offers benefits to patients and healthcare providers,” the interim CEO, Jones said in a statement.

Yep more than a glimmer..just need the cash to be returned!

The industry expects some details to emerge on what Finablr and local regulators intend to do with UAE Exchange. Will it go the way that the other D. B.R. Shetty founded enterprise – NMC Health – just announced? Of breaking up into much smaller enterprises and trying to find buyers for the rest?

Within Finablr, UAE Exchange was the crown jewel. Consumers’ trust in the brand and its services will need restoring before it can even think of a comeback.

Coming weeks will give some insight of what’s in store. But for now, some of the outlets have removed framed pictures of Dr. Shetty as the once famed brand distances itself from its legacy.

37% US

+28% boom